1. Home
  2. ATNM vs FIEE Comparison

ATNM vs FIEE Comparison

Compare ATNM & FIEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

SELL

Current Price

$0.97

Market Cap

37.1M

Sector

Health Care

ML Signal

SELL

Logo FiEE Inc

FIEE

FiEE Inc

N/A

Current Price

$3.64

Market Cap

31.3M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
FIEE
Founded
2000
1977
Country
United States
Hong Kong
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
37.1M
31.3M
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
ATNM
FIEE
Price
$0.97
$3.64
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $3.60
N/A
AVG Volume (30 Days)
★ 98.9K
5.9K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
★ 107.46
EPS
★ 0.71
0.17
Revenue
$90,000.00
★ $47,988,549.00
Revenue This Year
$19,344.45
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $1.41
$21.41
Revenue Growth
11.11
★ 27.58
52 Week Low
$0.74
$1.50
52 Week High
$1.74
$10.59

Technical Indicators

Market Signals
Indicator
ATNM
FIEE
Relative Strength Index (RSI) 34.56 44.04
Support Level $0.88 $3.50
Resistance Level $1.13 $3.97
Average True Range (ATR) 0.07 0.09
MACD -0.03 0.01
Stochastic Oscillator 1.27 40.00

Price Performance

Historical Comparison
ATNM
FIEE

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About FIEE FiEE Inc

FiEE Inc is a digital service provider focused on integrating artificial intelligence (AI) and data analytics into content creation, digital authentication, and brand management. Its business model leverages a cloud-based SaaS platform designed to support clients in developing, managing, and optimizing their digital presence across platforms, including customized graphics and posts, short videos, and editorial calendars aligned with brand goals. Additionally, it offers comprehensive software development and maintenance services, delivering custom software solutions from system design and development to deployment and post-launch maintenance. It services consist of three core areas: digital content and MCN services, software development services, and digital authentication services.

Share on Social Networks: